Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $59000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 53.17% to $59000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $181000.0 through Dec 2025, down 32.71% year-over-year, with the annual reading at $246000.0 for FY2025, 138.83% up from the prior year.
  • Depreciation & Amortization (CF) hit $59000.0 in Q4 2025 for Incannex Healthcare, down from $66000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $126000.0 in Q4 2024 to a low of -$5000.0 in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $47400.0 across 3 years, with a median of $60000.0 in 2025.
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 950.0% in 2024 and later plummeted 129.41% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $12000.0 in 2023, then skyrocketed by 950.0% to $126000.0 in 2024, then tumbled by 53.17% to $59000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for IXHL at $59000.0 in Q4 2025, $66000.0 in Q3 2025, and $61000.0 in Q2 2025.